Evidence map›Paper›PMID 42875174›Full record

ArticleInternational journal of epidemiology2026

Cohort Profile Update: The Adverse Events Questionnaire of Medications and Vaccines (ADE-Q) in the Estonian Biobank.

Kristi Krebs, Jelisaveta Džigurski, Liis Karo-Astover, Innar Hallik, Mairo Puusepp, Roger Kikkas, Sirje Lind, Helene Alavere, Kristjan Metsalu, Estonian Biobank Research Team and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kristi KrebsEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID 0000-0003-0494-2751
Jelisaveta DžigurskiEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID 0000-0003-2885-6241
Liis Karo-AstoverEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Innar HallikEstonian Biobank, Institute of Genomics, University of Tartu, Tartu, Estonia.
Mairo PuuseppEstonian Biobank, Institute of Genomics, University of Tartu, Tartu, Estonia.
Roger KikkasEstonian Biobank, Institute of Genomics, University of Tartu, Tartu, Estonia.
Sirje LindEstonian Biobank, Institute of Genomics, University of Tartu, Tartu, Estonia.
Helene AlavereEstonian Biobank, Institute of Genomics, University of Tartu, Tartu, Estonia.
Kristjan MetsaluEstonian Biobank, Institute of Genomics, University of Tartu, Tartu, Estonia.
Estonian Biobank Research Team
Jana LassEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Maris AlverEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID 0000-0001-6540-1460
Triin LaiskEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID 0000-0003-1501-9030
Lili MilaniEstonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.ORCID 0000-0002-5323-3102

Funding

Estonian Research Council PRG184Estonian Research Council PRG2625Estonian Research Council PSG776European UnionEuropean Union or the Health and Digital Executive AgencyEuropean Union's Horizon Europe Action 101057639Norway Grants "Green ICT" program EU53928Norwegian Financial Mechanism
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse drug eventsEstonian Biobankpharmacogenomics

Identifiers

PMID42875174
PMCPMC13668355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.